Scientific Letter

Correlation between prostate-specific antigen and bone scan findings in patients with prostate cancer at Grey’s Hospital, KwaZulu-Natal: A retrospective chart review

Farag Omar, Omran El-Koha, Wilbert Sibanda
South African Journal of Oncology | Vol 4 | a100 | DOI: https://doi.org/10.4102/sajo.v4i0.100 | © 2020 Farag Omar, Omran El-Koha, Wilbert Sibanda | This work is licensed under CC Attribution 4.0
Submitted: 04 September 2019 | Published: 30 January 2020

About the author(s)

Farag Omar, Department of Radiotherapy and Oncology, University of KwaZulu-Natal, Durban, South Africa
Omran El-Koha, Department of Radiotherapy and Oncology, University of KwaZulu-Natal, Durban, South Africa
Wilbert Sibanda, School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban, South Africa


Share this article

Bookmark and Share

Abstract

Many studies have indicated that prostate-specific antigen (PSA) is used for the detection and monitoring of prostate cancer. We analysed PSA levels and bone scan findings to determine whether PSA can accurately predict bone metastases. A study was conducted at Grey’s Hospital, a public hospital in Pietermaritzburg, KwaZulu-Natal, South Africa. A total of 84 patients were included in this study: 61 (72.62%) black patients, 14 (16.67%) Indian and 9 (10.71%) white patients. Our study indicated a high correlation between PSA level and bone scan finding. We arrived at a conclusion that at PSA level > 24 ng/mL, bone scan is highly recommended.

Keywords

PSA; bone scan; prostate; cancer correlation; Grey’s Hospital

Metrics

Total abstract views: 689
Total article views: 398


Crossref Citations

No related citations found.